人工智慧诊断市场:各零件,各诊断类型,各地区-规模,占有率,展望,机会分析,2023年~2030年
市场调查报告书
商品编码
1349867

人工智慧诊断市场:各零件,各诊断类型,各地区-规模,占有率,展望,机会分析,2023年~2030年

Artificial Intelligence Diagnostics Market, By Component, By Diagnosis Type, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录
根据预测,2022 年全球人工智慧 (AI) 诊断市场价值为 11.107 亿美元,预计到 2030 年将达到 57.736 亿美元,2023 年至 2030 年复合年增长率为 21.2%。

报告范围 报告详细资料
基准年 2022 2023 年市场规模 美国:15.029亿美元
过去的资料 2018年至2021年 预测期间 2023-2030
预测 2023-2030 年复合年增长率: 21.20% 2030年价值预测 57.736亿美元
人工智慧诊断市场-IMG1

人工智慧 (AI) 在医疗保健领域具有强大的潜力,有望快速、详细地分析大量数据。在体外诊断 (IVD) 等领域,这可能会产生变革性的影响。因此,医疗保健领域对人工智慧技术的需求日益增加。

市场动态:

随着人工智慧 (AI) 的发展和采用,医疗诊断实践正在迅速改变。电脑处理的不断改进使得基于人工智慧的系统能够在各个专业领域提供准确、高效的诊断和治疗管理计划。由于运算能力、学习演算法、云端储存以及电子病历资料集的可用性的进步,人工智慧可以在诊断和医疗保健领域发挥重要作用。人工智慧使放射科医生和病理学家能够在早期准确诊断医疗状况,以便提供适当和有效的治疗。

2017 年 12 月 PubMed 一篇关于人工智慧在放射学研究中应用的文章指出,下一个突破将不是来自创新的放射学设备,而是来自人工智慧的整合。这种整合可能会分阶段进行。基于人工智慧的设备透过超音波、MRI、CT 和 PET 等影像技术收集数据。作为第一步,人工智慧已经对各种影像资料和结构进行自动分割,为放射科医生提供了重要的分析价值并节省了时间。未来十年,基于人工智慧的放射学解决方案可能会用于在放射科医生进行分析之前执行定量、分割和模式识别等常规任务,从而改善患者护理。

本调查的主要特征

  • 本报告提供以2022年为基准年的预测期间(2023-2030 年)之全球人工智慧诊断市场的市场规模和復合年增长率(CAGR %)相关的详区隔析。
  • 并阐明不同部门市场的潜在收入机会,说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点,各类型投资组合、主要焦点、财务业绩和市场策略等参数,介绍全球人工智慧诊断市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察,将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球人工智慧诊断市场报告配合该行业的各种利益相关者,包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球人工智慧诊断市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市场动态,法规,趋势分析

  • 市场动态
    • 传染病增加
    • 关于使用温度计的担忧
    • 对人工智慧 (AI) 诊断设备的高需求
  • 影响分析
  • 主要的焦点
  • 法规情势
  • 产品销售/核准
  • PEST分析
  • 波特分析
  • 合併·收购情势

第4章 全球人工智慧诊断市场-冠状病毒(COVID-19)大流行病的影响

  • COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 人工智慧诊断的全球市场:各零件,2023-2030年

  • 软体
  • 硬体设备
  • 服务

第6章 人工智慧诊断的全球市场:各诊断类型,2020-2030年

  • 循环系统
  • 肿瘤学
  • 病理学
  • 放射线学
  • 神经学
  • 其他

第7章 人工智慧诊断的全球市场:各地区,2023-2030年

  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第8章 竞争情形

  • Vuno Inc.
  • CHC Healthcare Group
  • Aidoc
  • Imbio
  • Alivecor Inc.
  • Digital Diagnostics
  • Retina AI
  • Canon Medical Systems USA
  • Healthy IO
  • Milliman Inc.
  • GE Healthcare
  • Arterys
  • Alivecor Inc.
  • Riverain
  • Lucid Health
  • Qure.AI
  • Cardiologs

第9章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI6123

The global artificial intelligence (AI) diagnosis market was valued at US$ 1,110.7 Mn in 2022 and is forecast to reach a value of US$ 5,773.6 Mn by 2030 at a CAGR of 21.2% between 2023 and 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,502.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 21.20% 2030 Value Projection: US$ 5,773.6 Mn
Artificial Intelligence Diagnostics Market - IMG1

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study:

  • This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

  • Global Artificial Intelligence Diagnostics Market, By Component:
    • Software
    • Hardware
    • Services
  • Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
    • Cardiology
    • Oncology
    • Pathology
    • Radiology
    • Neurology
    • Others
  • Global Artificial Intelligence Diagnostics Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Vuno Inc.
    • CHC Healthcare Group
    • Aidoc
    • Imbio
    • Alivecor Inc.
    • Digital Diagnostics
    • Retina AI
    • Canon Medical Systems USA
    • Healthy IO
    • Milliman Inc.
    • GE Healthcare
    • Arterys
    • Alivecor Inc.
    • Riverain
    • Lucid Health
    • AI
    • Cardiologs

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Component
    • Market Snapshot, By Service Type
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising incidence of infectious diseases
    • Concerns about the use of thermometers
    • High demand for Artificial Intelligence (AI) diagnosis devices
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnosis Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Artificial Intelligence (AI) Diagnosis Market, By Component, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Hardware
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnosis Market, By Diagnosis Type, 2020-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Pathology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Radiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

7. Global Artificial Intelligence (AI) Diagnosis Market, By Geography, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)

8. Competitive Landscape

  • Vuno Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CHC Healthcare Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aidoc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Imbio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alivecor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Digital Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Retina AI
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems USA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Healthy IO
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Milliman Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Arterys
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alivecor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Riverain
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lucid Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qure.AI
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardiologs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us